Metabolites Shed by Intestinal Microbiota Keep Inflammation at Bay

by Colleen Fleiss on  May 8, 2018 at 1:14 AM Research News
RSS Email Print This Page Comment bookmark
Font : A-A+

Two key metabolites produced by the bacteria in mice that modulate inflammation in the host and could ultimately reduce the severity of non-alcoholic fatty liver disease, found study published in The Cell.
Metabolites Shed by Intestinal Microbiota Keep Inflammation at Bay
Metabolites Shed by Intestinal Microbiota Keep Inflammation at Bay

Non-alcoholic fatty liver disease (NAFLD) is a prevalent condition in Western countries, affecting up to 25 percent of adults, tracking along with trends in obesity and diabetes. The severity of symptoms can vary, ranging from simple steatosis, which is benign and asymptomatic, to non-alcoholic steatohepatitis (NASH), which is characterized by liver inflammation, swelling and fibrosis and can lead to cirrhosis and liver cancer. People who eat a high fat diet are more susceptible to NAFLD. Replicating that diet in mice, the researchers found that within just a few weeks, their intestinal microbiota changed character significantly, with some species of bacteria increasing and others decreasing. At the same time, an inventory of metabolites in the mouse's GI tract, serum and liver showed some metabolites known to be linked to intestinal microbiota to shift compared to mice on a low-fat diet. Three of those metabolites - tryptamine (TA), indole-3-acetate (I3A), and xanthurenic acid - were significantly depleted in high fat diet mice.

Show Full Article


"That's bad news for the liver," said Kyongbum Lee, Ph.D., professor of chemical and biological engineering at the School of Engineering at Tufts. "We demonstrated that two of these metabolites - I3A and TA - attenuate the effects of inflammation in several ways. Their depletion clears the way for disease to progress toward more serious stages." Some of those effects of I3A and TA include reducing the level of inflammation-inducing molecules (known as cytokines) like tumor necrosis factor alpha, interleukin-1-beta, and monocyte chemoattractant protein. The latter acts as an attractant for macrophages, which in turn produce more cytokines. All of these inflammatory agents are triggered by high levels of free fatty acid accumulation in the serum and liver - the hallmark of NAFLD, and the consequence of an unhealthy high fat diet.

Researchers also considered whether I3A and TA could be added back to the gut to help treat those with the more serious inflammatory stages of NAFLD. However, it was determined that high levels of TA are toxic. "Our focus now is on I3A, where we will be exploring whether I3A or other microbiota metabolites can change the course of disease," said Lee.

Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive